- Home
- ESTA vs INVA Comparison
ESTA vs INVA Comparison
Compare ESTA & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESTA | INVA |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ESTA | INVA |
|---|---|---|
| Price | $69.50 | $21.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $86.86 | $32.80 |
| AVG Volume (30 Days) | 276.7K | ★ 572.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 42.67 | ★ 816.67 |
| EPS | N/A | ★ 1.25 |
| Revenue | $61,208,000.00 | ★ $217,217,000.00 |
| Revenue This Year | $28.05 | $8.95 |
| Revenue Next Year | $26.21 | $12.65 |
| P/E Ratio | ★ N/A | $16.89 |
| Revenue Growth | ★ 76.49 | 62.63 |
| 52 Week Low | $37.37 | $16.52 |
| 52 Week High | $97.59 | $25.15 |
Technical Indicators
Market Signals| Indicator | ESTA | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 36.35 | 52.88 |
| Support Level | $67.94 | $20.44 |
| Resistance Level | $75.75 | $21.81 |
| Average True Range (ATR) | 2.89 | 0.40 |
| MACD | 0.18 | 0.03 |
| Stochastic Oscillator | 23.82 | 75.00 |
Price Performance
Historical ComparisonAbout ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.